Optimizing Effectiveness of Smoking Cessation Intervention During Low Dose CT Screening for Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03059940

Title field or adapter rule

{'original_value': 'Optimizing Effectiveness of Smoking Cessation Intervention During Low Dose CT Screening for Lung Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:28.327590+00:00

Published At

2026-10-29T00:00:00+00:00

Record Updated At

2026-10-29

Source Retrieved At

2026-10-31T22:18:03.495925+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Smoking Cessation"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-29", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT03059940"

protocolSection.identificationModule.officialTitle

"Optimizing Effectiveness of Smoking Cessation Intervention During Low Dose CT Screening for Lung Cancer"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["EARLY_PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Smoking Cessation (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Integrated Care (IC) Group', 'Quitline (QL) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Questionnaires completed at baseline and at 6 weeks, 12 weeks, and 6 months after the CT scan.', 'name': 'Questionnaires', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Integrated Care (IC) Group', 'Quitline (QL) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Participants have a CT scan of chest to look for signs of lung cancer.', 'name': 'Low Dose Computed Tomography Scan', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Integrated Care (IC) Group', 'Quitline (QL) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Participants given shared decision making and discussion about screening with the LDCT provider. Participants watch a short video about lung cancer, CT scans, and smoking cessation.', 'name': 'Shared Decision Making + Video', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Integrated Care (IC) Group', 'Quitline (QL) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Brief cessation counseling given by LDCT provider.', 'name': 'Cessation Counseling', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Quitline (QL) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Participants referred to the Quitline for counseling. Participants have 5 smoking cessation counseling sessions over the next 12 weeks.', 'name': 'Quitline', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Integrated Care (IC) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Participant informed of the risk, benefits and relative efficacy of cessation medications and to assess their medication preferences, expectations and medical suitability for either option. At the conclusion of this conversation the patient is provided with an initial supply of the medication jointly decided between provider and patient.', 'name': 'Pharmacotherapy Discussion', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Quitline (QL) Group'], 'description': "Nicotine patch dispensed. Dosing at physician's discretion.", 'name': 'Nicotine Patch', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Integrated Care (IC) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Varenicline or Buproprion prescribed by study doctor with directions of when and how much of anti-smoking drug that should be taken each time.', 'name': 'Anti-Smoking Drug', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Integrated Care (IC) Group'], 'description': 'Participant referred to Tobacco Treatment Program (TTP). TTP provides 4-8 counseling sessions and pharmacotherapy over a 10-12 week period,', 'name': 'Tobacco Treatment Program', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Integrated Care (IC) Group', 'Quitline (QL) Group', 'Quitline-Rx (QL-Rx) Group'], 'description': 'Participant asked to blow air through a CO-measuring device.', 'name': 'Carbon Monoxide (CO) Level Test', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Nicotine Patch (protocolSection.armsInterventionsModule.interventions[].name)
• Anti-Smoking Drug (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.